For generations, a diagnosis of age-related macular degeneration has been devastating. The entire AMD ecosystem has been organized around loss: loss of vision, loss of independence, loss of ability, loss of choice, and loss of hope.
Patients with early and intermediate AMD sat across from clinicians who, despite their best intentions, had little to offer beyond watchful waiting and careful management of inevitable vision loss. Patients who were unaware that they had AMD – and were suddenly diagnosed with wet AMD – were shocked by the urgency to take invasive treatment. Beyond the clinician’s office, independence and quality of life quietly eroded. Car keys got handed over, books put down, hobbies abandoned, faces of loved ones blurred. Patients’ lives shrank. The disease didn’t just steal their sight. It stole their purpose, identity, and sense of belonging. The things that make lives worth living.
Many AMD patients will tell you that these scenarios are still common, despite the fact that significant progress has been made on so many fronts. Not in a single moment or discovery, but in the accumulation of discoveries and innovations. We now have a better understanding of AMD risk and what drives it at every stage. New treatments are available. With a better understanding of risk we also have a better understanding of prevention. And assistive technologies have advanced greatly.
Every category has advanced, and yet the organizing principle for the whole system needs to formally catch up.
The insight that now defines this moment is deceptively simple: when every person in the ecosystem keeps the patient’s quality of life and independence at the center of their work, not as an afterthought, but as the organizing principle, processes and outcomes change profoundly. A patient who is seen as a whole life worth preserving, rather than a diagnosis to be managed, moves through the system differently.
They are caught earlier, educated more thoroughly, treated more ambitiously, prepared more honestly, and they arrive at each new milestone with more of themselves intact.
That shift is already underway, but it is still uneven and taking shape across the AMD ecosystem. When we talk about the New Narrative, it is not about introducing a new idea, but rather aligning around what is now possible. And most importantly, ensuring this is reflected in how we all think, communicate, and act on the patient’s behalf.
An AMD diagnosis is a call to action. Across every stage of disease and every part of the system, there’s opportunity to keep the patient’s quality of life and independence at the center of decision-making. It may seem obvious that the patient is at the center of decision-making, but the truth is, it’s easy to lose sight of the very human experience of living with macular degeneration.
We invite you to make that alignment real in your work by taking The AMD Patient-in-Mind Pledge. By taking this pledge, you commit to revisiting your goals again and again. To stress test everything you do through the filter of what’s most important to AMD patients — their quality of life.